LUMINOR Registry

Multicentric and prospective study. Real world registry including BTK and SFA lesions.

Device: luminor 14m & luminor 35

Number of patients: 215

Follow up: 12-month

Types of lesions: Stenotic or high occlusive lesions in femoropopliteal and below de knee arteries.

Luminor shows a freedom from target lesion revascularization higher than similar studies (89.60%), proving that luminor DCB is a reliable choice for the treatment of BTK lesions.

luminor

Dr. Vicente Riambau – Hospital Clínic (Barcelona, SPA)

Dr. Francisco Acín – Hospital Universitario de Getafe (Madrid, SPA)

All Clinical Trials
EFFPAC Trial
TINTIN Trial
MERLION Trial
BIBLIOS Trial